This inventor holds 4 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent. Top assignee: Intercept Pharmaceuticals, Inc.. Active years: 2018-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2020
Title: Ikuko Taoka: Innovator in Obeticholic Acid Formulations
Introduction
Ikuko Taoka is a notable inventor based in Toyonaka, Japan. He has made significant contributions to the field of pharmaceutical formulations, particularly focusing on obeticholic acid. With a total of 4 patents to his name, Taoka's work has implications for treating various diseases and conditions.
Latest Patents
Taoka's latest patents include innovative compositions of obeticholic acid and methods of use. These disclosures relate to formulations of obeticholic acid that exhibit improved stability, dissolution, and solubility. The methods outlined in these patents also detail the preparation of these formulations for therapeutic use.
Career Highlights
Ikuko Taoka is currently associated with Intercept Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work is pivotal in enhancing the efficacy of obeticholic acid in clinical applications.
Collaborations
Some of Taoka's notable coworkers include Richard Gail Lancaster and Kay Olmstead, who contribute to the collaborative efforts in their research endeavors.
Conclusion
Ikuko Taoka's innovative work in obeticholic acid formulations showcases his commitment to advancing pharmaceutical science. His contributions are vital for improving treatment options for various health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile